SeqOnce Biosciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant

SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.

AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence

CloudLIMS Announces Collaboration with Folio for Secure Issuance of COVID-19 Results to Patients

CloudLIMS’ COVID-19 LIMS solution has integrated with Folio's mobile app to enable receiving, storing, and sharing of COVID-19 test results securely and digitally.

NSTDA-BIOTEC selects Key Organics BIONET Fragment Library to identify new non-pyrimidine inhibitors of malaria parasite Plasmodium falciparum dihydrofolate reductase (PfDHFR).

In recent research at BIOTEC1 a three-step fragment-based screening of PfDHFR was undertaken employing Key Organics BIONET Premium library containing 1163 fragments. This library was chosen over other commercial ones as it is rule-of-three compliant and was curated from any PAINS and aggregating compounds. All fragments are also soluble at 200 mM in DMSO and display high diversity.

ComputaBio is Capable to provide Drug Design Services

ComputaBio, a US supplier of computational biology services, claims to be a capable helping hand in drug design for industrial and academic scientists worldwide to expedite their drug development projects.

VisualDx Launches Project IMPACT to Address Racism and Implicit Bias in Medicine

IntelyCare Hires David Burke as CFO to Drive Business Growth and Momentum; Address Intensifying Staffing Demands in Post-Acute Space

IntelyCare hires David Burke as chief financial officer to support the continued success and expansion of the company.

Alfa Chemistry: T,C&A Lab Unveils Ingredient Analysis Service

BOC Sciences Strengthens the Cooperation with Global Biotechnology Companies to Promote ADCs Development & Research

KCR opens new branch in Sydney, Australia

KCR, the international clinical development solutions provider, today announced the establishment of a new branch in Sydney, Australia. The new location will enhance KCR’s regional coverage and maximize clinical capabilities for clients across the globe.

Creative Biostructure Performs Comprehensive Lead Discovery and Optimization Solutions

KROHNE Features OPTIMASS 1000 Straight Tube Coriolis Mass Meter

KROHNE, Inc. features its OPTIMASS 1000 Straight Tube Coriolis Mass Meter manufactured at its state of the art flow and level instrument manufacturing and calibration facility located in Beverly, MA. OPTIMASS 1000 is designed for exceptional measurement capabilities with the flexibility and options of high-end meters, at a competitive price. The OPTIMASS 1000 is well-suited for a variety of industries, including the chemical, petrochemical, food and beverage, water and pharmaceutical, and can operate reliably between -40 and 130° C.

Pfannenberg Datawind Filterfans® Cool in IT Environments without Sacrificing Valuable Rack Space

Purpose-built product is ideal for space-restricted and manufacturing floor IT installations

Rousselot Biomedical joins European ENLIGHT project to develop a 3D living model of pancreatic tissue

In the European project ENLIGHT, researchers from academic centers and leading industries across Europe are joining forces to develop a living model of the pancreas to enable better testing of diabetes medication.

CellPort Software Announces Release of CellPort Cell Culture Suite

CellPort Software today announced the launch of the CellPort Cell Culture Suite, a new cloud-based Software as a Service (SaaS) product focused on cell culture and cell banking. CellPort Cell Culture Suite is a secure, compliant SaaS-based application suite focused on managing all lab workflows, activities, equipment, materials, personnel, data/calculations, locations, and projects for cell culture and cell banking. CellPort reduces errors, increases reproducibility, enhances productivity, and provides full audit-ready traceability for regulated and unregulated environments.

MedAI Releases Drug Formulation Development Service for the Pharmaceutical Industry

Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients

Biocept presents data showing its Target Selector molecular assay kit detects mutations in up to 50% of tissue biopsy specimens, from patients diagnosed with non-small cell lung cancer, that were deemed quantity not sufficient (QNS).

Healthtech company Raremark® reboots as XperiomeTM to drive increased value for rare disease patients and researchers

PHARMASEAL’s Engility® platform fights off competition to be selected by award-winning US Medical Device company

Whole Genome Sequencing for GutFlora Now Available by the GutFlora Omics Platform

The product manager of Creative Proteomics has recently announced the fully-developed whole-genome sequencing, which can work as a powerful tool in multiple areas including diagnosis, tracking disease outbreaks, characterizing causative mutations and identifying drug-resistance genes.